ThermoGenesis Holdings, Inc. Gains 42.86%

ThermoGenesis Holdings, Inc. (THMO:NASDAQ) shot up at $0.84, representing a gain of 42.9%. On Wed, Feb 07, 2024, THMO:NASDAQ hit a New 2-Week High of $0.84. From Wed, Jan 24, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days

About ThermoGenesis Holdings, Inc. (THMO:NASDAQ)

ThermoGenesis Holdings, Inc. is clinical-stage biotechnology company. The company is engaged in developing and manufacturing automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. The company's device division, ThermoGenesis Corp, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. ThermoGenesis Holdings, Inc.'s clinical development division is leveraging its proprietary AutoXpress technology platform to develop autologous stem cell-based therapies that address significant unmet needs in the immuno-oncology, vascular, cardiology and orthopedic markets.